{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-035285","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2024-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.822096+00:00","generated_at":"2026-05-31T06:04:38.193483+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Evofem and Aditxt amend merger agreement again; extend equity investment and closing deadlines","bullets":["Third Parent Equity Investment date moved from Sept 6 to Sept 30, 2024; Fourth from Sept 30 to Oct 31, 2024.","Outside consummation date (Section 8.1(b)(ii)) extended to November 29, 2024.","Aditxt must purchase $1.5M of Series F-1 preferred stock on each of the new Third and Fourth investment dates.","No other changes to merger terms; previous conditions and consideration unaffected."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-035285","json":"https://secwatch.observer/filing/0001493152-24-035285.json","markdown":"https://secwatch.observer/filing/0001493152-24-035285.md","text":"https://secwatch.observer/filing/0001493152-24-035285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224035285/0001493152-24-035285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224035285/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:04:38.193483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}